Combined synopsis and solicitation
National Drug Data File Renewal
CMMI-393-2024-0078-RAW
Centers for Medicare and Medicaid Services, Office of Acquisition Grants MGMT. All Other Publishers.
Awarded
$128,140.00 obligated so far on USAspending
Description
As published on SAM.gov.
INTENT TO AWARD SOLE SOURCE: The Centers for Medicare and Medicaid Services (CMS) intends to negotiate and award a sole source purchase order to the First Data Bank, 500 East 96th St., Suite 500, Indianapolis, IN 46240 to purchase a renew data license to the National Drug Data File (NDDF). Under the authority of FAR 6.301-1 10 U.S.C. 2304, Only One Responsible Source and No Other Supplies and Services Will Satisfy Agency Requirements in accordance with the attached Statement of Work.
A justification and approval are currently being processed for this requirement. This requirement is intended as a sole source procurement because First Data Bank (FDB) is the only source of the National NDDF, which CMS/CMMI needs to carry out research.
CMS REQUIREMENTS: Careful market research was performed and found FDB either purchases all other previously existing data sources, or the other data sources are no longer in existence. CMS uses NDDF exclusively for research and analysis projects related to Medicare and Medicaid programs. The specific statistical data supplied by FDB has been used by CMS for many years.
NAICS CODES: The North American Industry Classification System (NAICS) is 51140 (Director and Mailing List Publishers) and the size standard is 500 employees.
INTERESTED PARTIES: All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. In order to qualify as a potential contractor for this procurement, the identical data files (NDDF) must already be in existence and available to the contractor. FDB’s products include a complete line of drug databases, including clinical decision support and disease suite modules, applicators program interfaces, and standalone PC products.
The FDB databases include descriptive drug information, drug pricing, and drug identification. FDB’s unsurpassed clinical information and drug data, combined with Medi-Span’s drug databases are the most complete source of current and authoritative drug information available.
To be considered, interested vendors must submit technical literature describing their capability to effectively satisfy this requirement, as well as terms and conditions and a complete price quote on or before Friday, May 24, 2024 to the following electronic mail address: renee.wallaceabney@cms.hhs.gov
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- First Databank, Inc.
- UEI
- LUP2TRXNFW39
- CAGE
- 00YC0
- Vendor location
- South San Francisco, CA
- Contract
- 75FCMC24P0019, purchase order
- Obligated
- $128,140.00
- Actions
- 3 between August 15, 2024 and March 4, 2026
- Competition
- Not Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- 004175 Cmmi Title: Data Purchases. This Renewal Will Allow Continued Access to FDB Data.
- Match
- solicitation number CMMI39320240078RAW equals the FPDS solicitation identifier; same sub-agency 7530 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
May 9, 2024
Combined synopsis and solicitation
Due May 24, 2024 at 10:00 AM EDT. SAM.gov, notice daf379a8d1584e7bb0d3c008e358647a
Points of contact
- Renee Wallace-Abneyrenee.wallaceabney@cms.hhs.gov4107865128
- Phillip Harrellphillip.harrell@cms.hhs.gov4107868635